|
Agios Appoints David Scadden, M.D., to the Board of Directors
Nasdaq “Throughout Dr. Scadden’s career, he has made pioneering research achievements in hematology, and we are honored to welcome him to our board of directors,” said David Schenkein, M.D., chief executive officer of Agios. “The quality and strength of our … |
June 01, 2017 at 01:34AM
from
No comments:
Post a Comment